Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIXER Trial: Methotrexate for Prevention of PVR in Retinal Detachment Repair
NCT06541574Phase 2Recruiting
- Sponsor
- Cincinnati Eye Institute
- Start
- Mar 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in Proliferative Vitreoretinopathy (PVR), sponsored by Cincinnati Eye Institute. Started Mar 2024; status: recruiting.
02
Drugs
methotrexate
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT06541574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06541574.